Prenatal Screening at NTD
At NTD we recognize that pregnancy can be a time that raises many health related questions and concerns for your patients. For this reason, we strive to provide a comprehensive portfolio of prenatal screening services that deliver trusted, timely results, in order to better inform and empower both you and your patients.
Leading medical authorities recommend that all pregnant women be offered screening to evaluate the health of their baby and assess the overall health of the pregnancy. We are here to help you provide the best care for your patients.
NTD’s Premier Test:
Maternal Fetal ScreenSM |T1
The Most Comprehensive Overall Pregnancy Health Evaluation
Maternal Fetal ScreenSM | T1 is the only test to combine first-trimester aneuploidy risk assessment with early onset preeclampsia (EOPE) in one report—providing your patient with a comprehensive personalized risk result as early as 10 weeks’ gestation.
By combining ultrasound measurements with the analysis of five biochemical markers, MFS|T1 provides increased detection for Down Syndrome, at 98% with a 1.2% false positive rate. It also casts a wide net for other maternal and fetal issues, such as other aneuploidies, preeclampsia, low birth weight, fetal loss, and stillbirth.
-
Chromosomal Abnormalities
The chromosome abnormalities screened for in this test including:
-
Early onset preeclampsia
Preeclampsia is a serious hypertensive disorder in pregnancy. It can happen to any pregnant woman during the second half of her pregnancy. When it results in delivery before 34 weeks’ gestation, it is called “early-onset preeclampsia,” and is often more associated with morbidity and mortality.
-
Other obstetric complications
The analysis of the biological markers in mom’s blood may also offer insight for other maternal and fetal concerns such as low birth weight, fetal loss and stillbirth.